RejuvenRx Inc.
- Biotech or pharma, therapeutic R&D
RejuvenRx Inc. is an early stage biotech company leveraging its world-leading expertise in stem cell biology and the CoREST complex to develop first-in-class CoREST molecular glue degraders as disease-modifying medicines in hematology, oncology and aging.



